BIOEMTECH participated in the SNMMI 2026 Annual Meeting in Los Angeles, joining the nuclear medicine and molecular imaging community to discuss advances in radiopharmaceutical preclinical research.
Throughout the meeting, our team welcomed visitors at Booth No. 2660 and presented BIOEMTECH’s integrated approach to translational research, combining preclinical imaging systems with specialized CRO services. We were also pleased to contribute to the scientific programme with our poster presentation, “Intra-Therapy Imaging of Therapeutic Isotopes Validates Preclinical Radioligand Therapy Efficacy.”
We would like to thank everyone who visited us, shared their research needs and discussed future opportunities for collaboration. We look forward to continuing these conversations and supporting the development of innovative radiopharmaceuticals from preclinical evaluation towards clinical translation.